452 filings
Page 2 of 23
6-K
t7bj6r9k70w2h0e36tw
1 Dec 23
Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors
8:00am
6-K
l42 72la0414g1f
16 Nov 23
Current report (foreign)
8:00am
424B3
c490 ako87g
27 Oct 23
Prospectus supplement
4:15pm
EFFECT
pnol b8rwx605oegroy5
27 Oct 23
Notice of effectiveness
12:15am
CORRESP
i2lpa
25 Oct 23
Correspondence with SEC
12:00am
EFFECT
fkbe25h4 tc
24 Oct 23
Notice of effectiveness
12:15am
EFFECT
ak5 qwtjd
24 Oct 23
Notice of effectiveness
12:15am
UPLOAD
5hzpa gh7jsj90vvbtsa
24 Oct 23
Letter from SEC
12:00am
POS AM
ta1l4
20 Oct 23
Prospectus update (post-effective amendment)
4:29pm
POS AM
b2kf okvd810rse
20 Oct 23
Prospectus update (post-effective amendment)
4:28pm
F-3
uk55righwlhyvga2sr
20 Oct 23
Shelf registration (foreign)
4:23pm
D
c9d2fdx4rh d06k08v5c
19 Oct 23
$1.97 mm in equity / options / securities to be acquired, sold $1.97 mm, 11 investors
4:17pm
S-8
k5i k9095
12 Oct 23
Registration of securities for employees
4:43pm
6-K
nzndtzxw9zcde ws
29 Sep 23
Current report (foreign)
8:01am
6-K
y8x0awk1lg2a57
21 Sep 23
Akari Therapeutics Announces Existing Investors Support the Company
8:00am
6-K
prdjzwu 8snt
5 Sep 23
Current report (foreign)
9:00am
6-K
d5taiafn
18 Aug 23
from 6-K
8:00am
F-6 POS
fyd9edz412o
17 Aug 23
Automatic registration for ADRs (post-effective amendment, foreign)
4:27pm
6-K
pkcc9 zu2b9117ava5
15 Aug 23
Akari Therapeutics, Plc Announces ADS Ratio Change
8:00am
6-K
di4913 980ceig
2 Aug 23
Akari Therapeutics Announces the Appointment of Beth-Anne Lang as Senior Vice President, Regulatory Affairs
8:00am